Geron Corp. (GERN)

4.05
0.26 6.90
NASDAQ : Health Technology
Prev Close 3.79
Open 3.79
Day Low/High 3.75 / 4.20
52 Wk Low/High 1.74 / 6.68
Volume 7.80M
Avg Volume 6.94M
Exchange NASDAQ
Shares Outstanding 160.65M
Market Cap 608.88M
EPS -0.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Geron Corporation

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Geron Corporation

Levi & Korsinsky announces it has commenced an investigation of Geron Corporation ("Geron" or "the Company") (NASDAQGS: GERN) concerning possible violations of federal securities laws.

GERON CORPORATION INVESTOR ALERT: Girard Gibbs Investigates Potential Securities Law Violations

GERON CORPORATION INVESTOR ALERT: Girard Gibbs Investigates Potential Securities Law Violations

Girard Gibbs LLP is investigating claims on behalf of investors of Geron Corporation (NASDAQ:GERN) involving possible securities law violations.

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Geron Corporation - GERN

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Geron Corporation - GERN

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Geron Corporation (NASDAQ: GERN) resulting from allegations that Geron may have...

First Week Of May 18th Options Trading For Geron (GERN)

First Week Of May 18th Options Trading For Geron (GERN)

Investors in Geron Corp. saw new options begin trading this week, for the May 18th expiration.

Geron Corporation Reports Fourth Quarter And Annual 2017 Financial Results And Recent Events

Geron Corporation Reports Fourth Quarter And Annual 2017 Financial Results And Recent Events

Conference Call Scheduled for 8:30 a.m. ET on Monday, March 19

Small-Cap Stocks Are Doing Something They Haven't Done Consistently in 3 Years

Small-Cap Stocks Are Doing Something They Haven't Done Consistently in 3 Years

Small-cap stocks have finally jumped back to life on prospects for a strong U.S. economy this year. What trade war?

Geron To Host Analyst And Investor Meeting And Webcast On December 19, 2017

Geron To Host Analyst And Investor Meeting And Webcast On December 19, 2017

Management to be joined by external guest speaker to review imetelstat data from IMerge to be presented at the 59th American Society of Hematology Annual Meeting and Exposition

Geron Announces Presentations At American Society Of Hematology Annual Meeting

Geron Announces Presentations At American Society Of Hematology Annual Meeting

Imetelstat Clinical Data from Part 1 of IMerge in Myelodysplastic Syndromes to be Presented

Geron Shares Rise on Fast Track Designation -- Biotech Movers

Geron Shares Rise on Fast Track Designation -- Biotech Movers

The FDA granted fast track designation to imetelstat as a potential treatment for adults with with transfusion-dependent anemia.

Geron Announces Fast Track Designation Granted To Imetelstat For Lower Risk Myelodysplastic Syndromes

Geron Announces Fast Track Designation Granted To Imetelstat For Lower Risk Myelodysplastic Syndromes

Expanded Part 1 of IMerge is Open for Patient Enrollment

Geron Shares Take a Dive After J&J Unit-Led Trial Falters; Endo Closes Higher: Biotech Movers

Geron Shares Take a Dive After J&J Unit-Led Trial Falters; Endo Closes Higher: Biotech Movers

Geron and Endo and were among the biotech stock movers on Aug. 1.

Geron Announces Updates To Imetelstat Clinical Development

Geron Announces Updates To Imetelstat Clinical Development

Conference Call Scheduled for 8:00 a.m. ET on Tuesday, August 1

Commit To Buy Geron Corp. At $2, Earn 12.8% Annualized Using Options

Commit To Buy Geron Corp. At $2, Earn 12.8% Annualized Using Options

Investors eyeing a purchase of Geron Corp. stock, but tentative about paying the going market price of $2.96/share, might benefit from considering selling puts among the alternative strategies at their disposal.

First Week Of December 15th Options Trading For Geron (GERN)

Investors in Geron Corp. saw new options become available this week, for the December 15th expiration.

TheStreet Quant Rating: D+ (Sell)